CervoMed Inc. — Director's Dealing 2016

Sep 16, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Diffusion Pharmaceuticals Inc. (DFFN)
CIK: 0001053691
Period of Report: 2016-08-31

Reporting Person: BLECH ISAAC (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-31	Stock Option (Right to Buy)	$8	A	204907	Acquired	2026-08-31	Common Stock (204907)	Direct

Footnotes

F1: Security granted on August 31, 2016 under the Issuer's 2015 Equity Incentive Plan, as amended, as an initial one-time grant to the Reporting Person in connection with his appointment to the Issuer's Board of Directors on August 11, 2016.

F2: The option shall vest in 40 quarterly equal (or as nearly equal as possible) installments beginning September 30, 2016.